Article
Development and Application of a Cell-Based Assay for LRP4 Antibody Associated With Myasthenia Gravis
1 Jan 2023
Abstract excerpt
BACKGROUND AND PURPOSE: Among patients with double-seronegative myasthenia gravis (dSN-MG) who do not have detectable antibodies against acetylcholine receptor or muscle-specific tyrosine kinase, autoantibodies against low-density lipoprotein receptor-related protein 4 (LRP4-Ab) have been detected recently. The purpose of this study was to develop an in-house cell-based assay (CBA) to detect LRP4-Ab and to apply...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
